1. Wang F^#, Fu K^#, Wang Y, Pan C, Wang X, Liu Z, Yang C, Li X, Lu Y, To KK^*, Xia C^*, Zhang J^*, Shi Z^*, Hu Z^*, Huang M^*, Fu L^* Small-molecule agents for cancer immunotherapy. Acta Pharmaceutica Sinica B. 2024;14(3):905-952 (IF=14.5)

2. Liu C, Xia C*, Xia C*. Biology and function of exosomes in tumor immunotherapy. Biomed Pharmacother. 2023;169:115853(IF=7.5)

3. Mai Y, Su J, Yang C, Xia C*, Fu L*. The strategies to cure cancer patients by eradicating cancer stem-like cells. Mol Cancer. 2023 Oct 18;22(1):171 (IF=37.3)

4. Xia C^*,Yin S,To K., Fu L^* Targeting the CD39/CD73/A2AR Pathway in Immunosuppressive Tumor Microenvironments. Mol Cancer. 2023;22(1):44 (IF=37.3)

5. Xia C, Su J, Liu C, Mai Z, Yin S, Yang C, Fu L^* Human Microbiomes in Cancer Development and Therapy. MedComm(2020). 2023;4(2):e221(IF=9.9)

6. Yin S, Mai Z, Liu C, Xu L^*, Xia C^* Label-free-based quantitative proteomic analysis of the inhibition of cisplatin-resistant ovarian cancer cell proliferation by cucurbitacin B  Phytomedicine. 2023;111:154669 (IF=7.9)

7.  Xia C^*, Liu C, He Z, Cai Y, Chen J. Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression. J Exp Clin Cancer Res 2020;39(1):127. (IF=11.1)